Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_assertion type Assertion NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_head.
- NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_assertion wasGeneratedBy ECO_0000203 NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_provenance.
- NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_assertion wasDerivedFrom befree-2016 NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_provenance.
- NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_assertion SIO_000772 17921715 NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_provenance.
- NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_assertion evidence source_evidence_literature NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_provenance.
- NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_assertion description "[COX-2 and NF-KB overexpression is common in pancreatic cancer but does not predict for COX-2 inhibitors activity in combination with gemcitabine and oxaliplatin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_provenance.